Ann: OPMD Orphan Disease Program Update, page-4

It will likely run a little to match what has happened today on the ASX, but when we GET orphan status, I’d expect another bump. But when the trial for head and neck cancer starts, that’s when I personally expect to see a more significant and sustained rise in share price. Unless something else happens that we’re not anticipating.